Therapy Areas: Inflammatory Diseases
Pfizer names new Regional President for Middle East, Russia and Africa
6 September 2024 - United States-based pharmaceutical and biotechnology corporation Pfizer announced on Thursday that it has named Elif Aral as its new regional president for Middle East, Russia and A...
GSK's Nucala approved in Japan for chronic rhinosinusitis with nasal polyps
28 August 2024 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) announced on Wednesday that it has received approval from Japan's Ministry of Health, Labour and Welfare for Nucala (mepo...
RedHill Biopharma's Opaganib receives US FDA orphan-drug designation
27 August 2024 - Israel-based specialty biopharmaceutical company RedHill Biopharma Ltd. (Nasdaq: RDHL) announced on Monday that it has received orphan-drug designation from the US Food and Drug Admin...
Lipella launches OLP Patient Registry to advance research
22 August 2024 - Clinical-stage biotechnology company Lipella Pharmaceuticals Inc (NASDAQ:LIPO) announced on Thursday the launch of an Oral Lichen Planus (OLP) Patient Registry.This online platform ai...
Talphera enrols first subject in NEPHRO CRRT study
20 August 2024 - California-based specialty pharmaceutical company Talphera, Inc. (Nasdaq: TLPH) announced on Monday that it has enrolled its first subject in the NEPHRO CRRT study.The NEPHRO CRRT reg...
Pfizer reports positive results for ABRYSVO RSV vaccine in immunocompromised adults
12 August 2024 - Biopharmaceutical company Pfizer Inc (NYSE: PFE) on Monday reported encouraging top-line results from a Phase 3 clinical trial evaluating its ABRYSVO vaccine for respiratory syncytial...